It will be an ADR for a foreign company like Gmed, not a new IPO...

It will be an ADR for a foreign company like Gmed, not a new IPO for usa based company.
https://business.nasdaq.com/list/index.html
its also not easy to trace ADR here as well.
$
Per Jan19 update to asx, F1 has been submitted to SEC. Thats a fact.
Perhapa try asking "investor relation, if new one has been appointed", or ask Yacov, or wait for update, befor making any presumption re Nasdaq x_listing date delay.
$
i am still betting on us getting some *major news in one shape or form, in 3-6 weeks time.
$
As kramer says, next few weeks *before 8May* is crucial for Yacov to come up with a substantial POs to earn his 50m perf shares (82% x 60M).
$
If another u$22m POs comes days or weeks after 8May, Yacov would have missed out 50m perf shares. It wont be an issue for me as a shh; it means our owneship is not diluted by 25% (60m/382m SOI). However, I prefer Yacov to get it..he deserves it, for where Gmed is today, since May2017. A doer, not a talker nor leaker.
$
Aimo, Do your own homework.